" Absolutely, we are working on all aspect of this
Post# of 148281
Now WHY was it again we thought GVDH was on the backburner?
Oh, yes, the 10-Q from ONLY 3 DAYS AGO !:
"The Company will require a significant amount of additional capital to complete the foregoing clinical trials for HIV and complete its BLA
submission, as well as to advance its trials for GvHD and certain cancer indications. (...)
Phase 2 Trial for Graft-versus-Host Disease (...) Due to the necessary prioritization of limited capital, enrollment under the amended protocol has been delayed. (...)"
So, now we're working on GVHD while 3 days earlier we could not afford to.
Now, what is it please mr NP?